10 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Halyard Purple Nitrile* Powder-Free Exam Gloves, Low Dermatitis Potential, Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Simulated Gastric Acid and Fentanyl in Simulated Gastric Acid

FDA 510(k)
FDA Class 1 ·General Hospital

Burr

FDA UDI
KATENA PRODUCTS, INC.·00841668113080·BURR FOR ALGERBRUSH 0.5MM

COLLAGEN DENTAL MEMBRANE - CONFORMABLE PP

FDA 510(k)
FDA Class 2 ·Dental

VASCULAR SOLUTIONS LANGSTON DUAL LUMEN PIGTAIL CATHETER (DLP)

FDA 510(k)
FDA Class 2 ·Cardiovascular

SAMSUNG GALAXY WATCH 5 PRO (Z9NL)

FDA Adverse Event
Malfunction ·SAMSUNG ELECTRONICS AMERICA, INC.·Product code QDA·May 26, 2026

CLINICAL INFO CENTER

FDA Adverse Event
Malfunction ·GE HEATHCARE·Product code MHX·November 19, 2008

FEMORAL COMPONENT

FDA Adverse Event
Injury ·SMITH & NEPHEW, INC·Product code JDH·September 9, 2011

MOTORIZED 3-WHEELED VEHICLE FOR OUTSIDE TRANSPORT

FDA Adverse Event
C.T.M. HOMECARE PRODUCT, INC·Product code INI·July 22, 2013

PTCA KIT W/03ML FLUSH DEVICE FOR WILLIAMSPORT HOSP, Item No. 46095-22 The Transpac Disposable Straight Pressure Transducer (DSPT) is an extravascular pressure transducer that interfaces between a catheter and pressure monitor by converting changes in pressure into electrical currents that can be input into a compatible pressure monitor. The SafeSet Reservoir system is a blood sampling system assembled directly to the patient monitoring line (Transpac units). The SafeSet reservoir is used on patients where periodic blood sampling is required.

FDA Enforcement
Class II ·Terminated·ICU Medical, Inc.·November 23, 2016

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014